Kondisi
16 kondisi kesehatan dengan penelitian suplemen berbasis bukti
We evaluate supplements across specific hair and scalp conditions. Each condition page ranks ingredients by evidence grade, helping you find what research actually supports for your particular concern.
How We Grade Evidence
Setiap halaman kondisi memberi peringkat bahan suplemen berdasarkan kekuatan bukti klinis. Berikut arti dari setiap peringkat:
Strong Evidence
Multiple randomized controlled trials (RCTs) or meta-analyses with consistent positive results and large sample sizes.
Good Evidence
At least one RCT with mostly consistent results across studies. Evidence suggests benefit but more research may be needed.
Some Evidence
Small studies or observational data with some positive signals. Promising but insufficient for strong recommendations.
Very Early Research
In vitro studies, case reports, or pilot studies only. Early-stage research that requires clinical validation.
Alopecia Androgenetik
50% of men by age 50, 25% of women by age 50
Alopecia Areata
2% lifetime risk
Alopecia Traksi
Common in certain hairstyle practices
Kerontokan Rambut Akibat Defisiensi Nutrisi
Common in restrictive diets and malabsorption conditions
Kerontokan Rambut Akibat Defisiensi Zat Besi
Affects up to 60% of premenopausal women with hair loss
Kerontokan Rambut Akibat Kemoterapi
Affects 65-85% of chemotherapy patients depending on regimen
Kerontokan Rambut Akibat Psoriasis Kulit Kepala
45-56% of psoriasis patients have scalp involvement
Kerontokan Rambut Pascapersalinan
Affects 40-50% of women postpartum
Kerontokan Rambut Pola Wanita
40% of women by age 50
Kerontokan Rambut Terkait Stres
Increasingly common; associated with telogen effluvium
Kerontokan Rambut Terkait Tiroid
4-10% of general population has thyroid dysfunction
Penipisan Rambut Terkait Usia
Near-universal over age 60
Peradangan Kulit Kepala (Folikulitis & Dermatitis)
Seborrheic dermatitis affects 3-5% of adults; scalp involvement very common
Perubahan Rambut Hormonal (PCOS & Menopause)
PCOS affects 6-12% of women; menopause-related thinning affects 40%+ of postmenopausal women
Sindrom Rambut dan Kuku Rapuh
Affects approximately 20% of the general population
Telogen Effluvium
Second most common cause of hair loss
Penafian FDA: Pernyataan-pernyataan ini belum dievaluasi oleh Food and Drug Administration. Produk dan informasi di situs web ini tidak dimaksudkan untuk mendiagnosis, mengobati, menyembuhkan, atau mencegah penyakit apa pun. Peringkat bukti yang disajikan didasarkan pada analisis kami terhadap penelitian yang ditinjau sejawat dan tidak merupakan saran medis. Selalu konsultasikan dengan penyedia layanan kesehatan Anda sebelum memulai regimen suplemen apa pun.